Stay updated on Exebacase in COVID-19 MRSA Clinical Trial
Sign up to get notified when there's something new on the Exebacase in COVID-19 MRSA Clinical Trial page.

Latest updates to the Exebacase in COVID-19 MRSA Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check23 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference3%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check66 days agoChange DetectedThe page has undergone significant content removal regarding the Expanded Access Study for exebacase treatment of MRSA bloodstream infections, including detailed eligibility criteria and study descriptions. A new version number has been added, indicating an update.SummaryDifference25%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
Stay in the know with updates to Exebacase in COVID-19 MRSA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exebacase in COVID-19 MRSA Clinical Trial page.